Key points are not available for this paper at this time.
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The diversity and considerable morphologic overlap of bone tumors with other mesenchymal and nonmesenchymal bone lesions can complicate diagnosis. Accurate histologic diagnosis is crucial for appropriate management and prognostication. Since the publication of the fourth edition of the World Health Organization (WHO) classification of tumors of soft tissue and bone in 2013, significant advances have been made in our understanding of bone tumor molecular biology, classification, prognostication, and treatment. Detection of tumor-specific molecular alterations can facilitate the accurate diagnosis of histologically challenging cases. The fifth edition of the 2020 WHO classification of tumors of soft tissue and bone tumors provides an updated classification scheme and essential diagnostic criteria for bone tumors. Herein, we summarize these updates, focusing on major changes in each category of bone tumor, the newly described tumor entities and subtypes of existing tumor types, and newly described molecular and genetic data.
Building similarity graph...
Analyzing shared references across papers
Loading...
Joon Hyuk Choi
Yeungnam University
Jae Y. Ro
Inje University
Advances in Anatomic Pathology
Cornell University
Methodist Hospital
Yeungnam University
Building similarity graph...
Analyzing shared references across papers
Loading...
Choi et al. (Wed,) studied this question.
synapsesocial.com/papers/69d85d3038c00da8b4bed9f1 — DOI: https://doi.org/10.1097/pap.0000000000000293
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: